Welcome to This Week in Infectious Disease. This week we're covering 10 notable papers spanning the global fight against antimicrobial resistance, new insights into host immunology and viral reservoirs, and key updates in prevention and therapeutics. We'll also note two important dispatches from the field on drug-resistant malaria and the Sudan Virus. Let's dive in.

This week's papers:

1. Global, regional, and national impact of the Expanded Programme on Immunization against 14 pathogens from 1974 to 2024: an economic evaluation. — The Lancet. Global health 2026
2. Plasma signals of lung tumor promotion for molecular cancer prevention. — Cell 2026
3. Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease: The TRACK Randomized Clinical Trial. — JAMA 2026
4. A natural depsipeptide antibiotic binds the E-site of the bacterial ribosome. — Nature 2026
5. Kidney Transplantation in Two Highly Sensitized Candidates after CAR T-Cell Therapy. — The New England journal of medicine 2026
6. Intravenous Artesunate in Artemisinin-Resistant Severe Malaria in Uganda. — The New England journal of medicine 2026
7. Sudan Virus Disease in Uganda, 2025. — The New England journal of medicine 2026
8. HIV-1 infection converts CD4T cells to HLA class II-restricted CD8T cells. — Science translational medicine 2026
9. Limitations of Global Surveillance for Neisseria gonorrhoeae Antimicrobial Resistance. — Emerging infectious diseases 2026
10. Future-proofing tuberculosis therapy: framework for concurrent drug and resistance testing development. — The Lancet. Infectious diseases 2025

Listen at AudioScholar